BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027

Feb.03
BAT CEO: to ramp up ‘next-generation’ tobacco capacity in Italy, plans €500 mln investment in Trieste plant by 2027
British American Tobacco (BAT) CEO Tadeu Marroco said the group will continue to invest in equipment and technology in Italy and expand capacity for next-generation tobacco products such as e-cigarettes and heated tobacco. BAT’s Trieste innovation hub is slated to receive a total investment of 500 million euros by 2027 and add 16 new production lines.

Key points at a glance

 

  • Stepping up manufacturing in Italy: Continued spending on equipment and technology, with expanded capacity for smoke-free products.
  • Localised supply chain: Marroco said roughly 80% of machinery purchased for BAT factories worldwide comes from Italian companies, while more than 80% of BAT’s suppliers in Italy are domestic SMEs.
  • Limited impact from higher excise duties: BAT expects a manageable effect from Italy’s multi-year excise increases and said it pays about 2 billion euros a year in Italy in excise and VAT.
  • Securing leaf tobacco purchases: BAT plans to buy up to 15,000 tonnes of Italian tobacco in 2026–2028, supporting more than 400 SMEs and around 6,000 jobs.
  • Capacity expansion and sales mix: Trieste is adding 16 production lines; next-generation products account for about 18% of group revenue and around 45% in Italy, Marroco said.

 


 

2Firsts, Feb 3, 2026

 

According to Milano Finanza, Marroco said BAT will keep investing in production equipment and technology in Italy while building capacity for next-generation tobacco products, including vaping and heated tobacco, and maintaining its local tobacco leaf procurement. He spoke during a visit to Rome for meetings with institutions and stakeholders.

 

Marroco said around 80% of machinery BAT buys for its factories worldwide is supplied by Italian companies, and that more than 80% of BAT’s suppliers in Italy are domestic small and medium-sized enterprises. He cited Brazil as a contrasting case, saying a ban on e-cigarettes there has fuelled the spread of illicit devices, undermined oversight and public finances, and increased health risks.

 

On taxation, Italy’s latest budget includes further multi-year increases in excise duties on cigarettes and tobacco products, rising to as much as 0.15 euros per pack in 2026, with an expected 213 million euros in additional revenue this year. Marroco said the measures had been planned and would have a limited impact on BAT’s business. He added that BAT pays about 2 billion euros a year to the Italian state in excise and VAT. He also said fiscal stability helps deter tax evasion and curb illicit trade, noting the illicit market in Italy accounts for about 4.5%.

 

Looking at BAT’s long-term commitments in Italy, Marroco recalled the group’s 2004 acquisition of Italy’s state tobacco assets for 2.3 billion euros and said Italy remains one of BAT’s key markets. He said BAT will purchase up to 15,000 tonnes of Italian tobacco over 2026–2028, supporting more than 400 SMEs employing around 6,000 people, under a three-year protocol renewed in 2025 between BAT Italy and the Ministry of Agriculture, Food Sovereignty and Forests (MASAF).

 

On manufacturing, Marroco said BAT opened its Trieste innovation hub in 2023 and plans to invest a total of 500 million euros by 2027. As 16 additional production lines announced last September ramp up to full capacity, the site is expected to generate employment impacts for about 2,700 people over five years, while total capacity is set to double compared with the original industrial plan, which envisaged up to 12 lines by 2027.

 

On the group’s transition targets, Marroco said BAT aims for non-combustible products to account for 50% of revenue by 2035. He said the share currently stands at about 18% at group level, with Italy at around 45%. Marroco added that BAT invests about 350 million pounds a year in scientific research. On results for 2025, he said BAT would present them shortly and that he was optimistic about growth, citing improved performance in the U.S. market, which he said represents about 50% of group revenue, while noting lengthy U.S. FDA authorisation processes can slow innovation and increase the share of illicit products.

 

Cover image source: Tobacco Reporter

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Canadian Border Officers Seize Contraband Worth CAD 4.5 Million at Point Edward Crossing
Canadian Border Officers Seize Contraband Worth CAD 4.5 Million at Point Edward Crossing
The Canada Border Services Agency said border officers at the Point Edward port of entry in Sarnia, Ontario, seized more than CAD 4.5 million worth of illegal tobacco and nicotine vapes over a seven-day period. The agency said the contraband was entering Canada from the United States and described the seizure as part of ongoing efforts to prevent illegal products from entering the country and disrupt organized crime.
Mar.26 by 2FIRSTS.ai
Smoore International Q1 Results: Enterprise-Focused Business Up 48.6% Year-on-Year, Proprietary E-Vapor Brand Business Up 14.3%
Smoore International Q1 Results: Enterprise-Focused Business Up 48.6% Year-on-Year, Proprietary E-Vapor Brand Business Up 14.3%
Smoore International reported its Q1 financial results, with revenue for the period reaching RMB3.856 billion, up 41.7% year-on-year, and net profit (profit for the period) totaling RMB262.5 million, up 36.6% year-on-year. Revenue from its enterprise-focused business was RMB3.2674 billion, representing a 48.6% increase from RMB2.1989 billion in the same period last year. Revenue from its proprietary brand business was RMB588.6 million, up 12.6% from RMB522.6 million a year earlier.
Apr.10 by 2FIRSTS.ai
PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Spain’s Galicia Moves First: Under-18 Vape and Energy Drink Sales and Use Banned
Galicia will implement a new “Minor Health Protection and Addictive Behaviors Prevention” law this Saturday, becoming the first region in Spain to ban the sale and use of vapes for people under 18.
Mar.09 by 2FIRSTS.ai
Australia’s Tasmania Tables New Bill to Strengthen Crackdown on Illicit Tobacco and Vapes
Australia’s Tasmania Tables New Bill to Strengthen Crackdown on Illicit Tobacco and Vapes
The Tasmanian government has tabled the Public Health Amendment (Prohibited Tobacco and Other Products) Bill 2026 in Parliament, proposing new offences, higher penalties and stronger enforcement powers to crack down on illicit tobacco and vaping products.
Mar.25 by 2FIRSTS.ai
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
China Tobacco Jiangsu Industrial Patent Points to 3D-Printed Nicotine Oral Products
Jiangsu China Tobacco Industrial Co., Ltd. has disclosed a patent describing a nicotine oral formulation produced using 3D printing technology. The invention enables a three-stage nicotine release system—rapid onset, sustained delivery and long-term release—through a layered structure with varying porosity. The technology reflects growing experimentation within China Tobacco’s research system around precision nicotine delivery for modern oral products.
Mar.09